Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Nov 21, 2022
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2022Buy(P)943$2.62$2K166K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-020707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML